Skip to main content
. 2022 Feb 21;10(2):340. doi: 10.3390/vaccines10020340

Table 2.

Reported reactogenicity events in vaccine recipients.

Stage Cohort Number of Subjects with Reactogeni-City Events Reacto-Genicity Event Study Day Number of Vaccinees (%) Number of Events Severity (Grade)
Stage 1 1D 2 Diarrhea D1 1 (12.5%) 1 Mild
Nausea D1 1 (12.5%) 1 Moderate
Vomiting D1 1 (12.5%) 1 Mild
Stage 2 2A 1 Nausea D4 1 (12.5%) 1 Mild
2B 2 Nausea D4 1 (12.5%) 1 Mild
D7 1 (12.5%) 1 Mild
Vomiting D1 2 (25%) 2 Mild
D7 1 (12.5%) 1 Mild
2C 1 Diarrhea D11 1 (12.5%) 1 Mild
Vomiting D1 1 (12.5%) 1 Mild
D4 1 (12.5%) 1 Mild
D7 1 (12.5%) 1 Mild
D10 1 (12.5%) 1 Mild